The authors define molecular imaging, according to the Society of Nuclear Medicine and
Molecular Imaging, as the visualization, characterization, and measurement of biological …

Cystic renal cell carcinoma (RCC) is almost certainly overdiagnosed and overtreated. Efforts
to diagnose and treat RCC at a curable stage result in many benign neoplasms and indolent …

Purpose: This AUA Guideline focuses on evaluation/counseling and management of adult
patients with clinically localized renal masses suspicious for cancer, including solid …

Context The incidental detection of localized renal masses has been rising steadily, but a
significant proportion of these tumors are benign or indolent and, in most cases, do not …

Purpose: Clinical practice varies widely on the diagnostic role of biopsy for clinically
localized renal masses suspicious for renal cell carcinoma. Therefore, we performed a …

The widespread use of cross-sectional imaging has led to a continuous increase in the
number of incidentally detected indeterminate renal masses. Frequently, these clinical …

Purpose Imaging plays a key role throughout the renal cell carcinoma (RCC) patient
pathway, from diagnosis and staging of the disease, to the assessment of response to …

Oncocytoma is a well-defined benign renal tumor, with classic gross and histologic features,
including a tan or mahogany-colored mass with central scar, microscopic nested …

Objectives Solid renal masses have unknown malignant potential with commonly utilized
imaging. Biopsy can offer a diagnosis of cancer but has a high non-diagnostic rate and …

Novel molecular imaging opportunities to preoperatively diagnose renal cell carcinoma is
under development and will add more value in limiting the postoperative renal function loss …